Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.32
ADUS's Cash-to-Debt is ranked higher than
52% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. ADUS: 0.32 )
Ranked among companies with meaningful Cash-to-Debt only.
ADUS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.11 Max: No Debt
Current: 0.32
Equity-to-Asset 0.69
ADUS's Equity-to-Asset is ranked higher than
81% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. ADUS: 0.69 )
Ranked among companies with meaningful Equity-to-Asset only.
ADUS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.59 Max: 0.76
Current: 0.69
0.26
0.76
Interest Coverage 6.53
ADUS's Interest Coverage is ranked lower than
52% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 7.25 vs. ADUS: 6.53 )
Ranked among companies with meaningful Interest Coverage only.
ADUS' s Interest Coverage Range Over the Past 10 Years
Min: 1.02  Med: 5.83 Max: 25.89
Current: 6.53
1.02
25.89
Piotroski F-Score: 4
Altman Z-Score: 5.89
Beneish M-Score: -2.08
WACC vs ROIC
1.59%
7.11%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 3.80
ADUS's Operating Margin % is ranked lower than
66% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 6.49 vs. ADUS: 3.80 )
Ranked among companies with meaningful Operating Margin % only.
ADUS' s Operating Margin % Range Over the Past 10 Years
Min: 2.59  Med: 4.68 Max: 6.41
Current: 3.8
2.59
6.41
Net Margin % 3.00
ADUS's Net Margin % is ranked lower than
56% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. ADUS: 3.00 )
Ranked among companies with meaningful Net Margin % only.
ADUS' s Net Margin % Range Over the Past 10 Years
Min: -0.86  Med: 2.81 Max: 7.2
Current: 3
-0.86
7.2
ROE % 8.10
ADUS's ROE % is ranked lower than
55% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. ADUS: 8.10 )
Ranked among companies with meaningful ROE % only.
ADUS' s ROE % Range Over the Past 10 Years
Min: -10.67  Med: 7.58 Max: 18.38
Current: 8.1
-10.67
18.38
ROA % 5.37
ADUS's ROA % is ranked higher than
62% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. ADUS: 5.37 )
Ranked among companies with meaningful ROA % only.
ADUS' s ROA % Range Over the Past 10 Years
Min: -1.23  Med: 4.34 Max: 12.2
Current: 5.37
-1.23
12.2
ROC (Joel Greenblatt) % 24.85
ADUS's ROC (Joel Greenblatt) % is ranked higher than
60% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 15.74 vs. ADUS: 24.85 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ADUS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 16.92  Med: 29.03 Max: 43.85
Current: 24.85
16.92
43.85
3-Year Revenue Growth Rate 13.70
ADUS's 3-Year Revenue Growth Rate is ranked higher than
66% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. ADUS: 13.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ADUS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -54.8  Med: 3.4 Max: 13.7
Current: 13.7
-54.8
13.7
3-Year EBITDA Growth Rate 10.90
ADUS's 3-Year EBITDA Growth Rate is ranked higher than
58% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. ADUS: 10.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ADUS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -52.9  Med: 2.9 Max: 10.9
Current: 10.9
-52.9
10.9
3-Year EPS without NRI Growth Rate 1.30
ADUS's 3-Year EPS without NRI Growth Rate is ranked lower than
65% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. ADUS: 1.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ADUS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 1.3  Med: 8.7 Max: 35.1
Current: 1.3
1.3
35.1
GuruFocus has detected 1 Warning Sign with Addus HomeCare Corp $ADUS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ADUS's 10-Y Financials

Financials (Next Earnings Date: 2017-06-06 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

ADUS Guru Trades in Q1 2016

Chuck Royce Sold Out
Jim Simons 133,500 sh (-14.75%)
» More
Q2 2016

ADUS Guru Trades in Q2 2016

Jim Simons 84,200 sh (-36.93%)
» More
Q3 2016

ADUS Guru Trades in Q3 2016

Jim Simons 50,100 sh (-40.50%)
» More
Q4 2016

ADUS Guru Trades in Q4 2016

Jim Simons 12,300 sh (-75.45%)
» More
» Details

Insider Trades

Latest Guru Trades with ADUS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8082
Compare:OTCPK:MFCSF, OTCPK:RLGHF, NAS:BIOS, NYSE:QHC, NYSE:CCM, NYSE:AAC, NAS:PRSC, AMEX:HLTH, OTCPK:MIHI, OTCPK:COLRF, NAS:AFAM, OTCPK:CATS, OTCPK:AMEH, NAS:JYNT, OTCPK:FCHS, NYSE:ADPT, OTCPK:CCEL, OTCPK:BNKL, AMEX:AMS, OTCPK:CVHIF » details
Traded in other countries:A41.Germany,
Addus HomeCare Corp provides home and community based services, which are mainly social in nature and are provided in the home, focused on the dual eligible population.

Addus HomeCare Corp was incorporated in Delaware in 2006 under the name Addus Holding Corporation for the purpose of acquiring Addus HealthCare, Inc. The Company provides home and community based services, which are mainly social in nature and are provided in the home, focused on the dual eligible population. Its services include personal care and assistance with activities of daily living, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, commercial insurers and private individuals. It provides home and community based services through over 121 locations across 21 states to over 26,000 consumers. The home and community based services the company provides are mainly social in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living. It provides these services on a long-term, continuous basis, with an average duration of approximately 17 months per consumer. Its adult day centers provide a comprehensive program of skilled and support services and designated medical services for adults in a community-based group setting. Services provided by Company's adult day centers include social activities, transportation services to and from the centers, the provision of meals and snacks, personal care and therapeutic activities such as exercise and cognitive interaction. The Company competes with home and community based service providers, home health providers, private caregivers, larger publicly held companies, privately held companies, privately held single-site agencies, hospital-based agencies, not-for-profit organizations, community-based organizations, managed care organizations and self-directed care programs. Its business is subject to extensive and increasing federal, state and local regulation.

Ratios

vs
industry
vs
history
PE Ratio 29.16
ADUS's PE Ratio is ranked lower than
61% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 27.32 vs. ADUS: 29.16 )
Ranked among companies with meaningful PE Ratio only.
ADUS' s PE Ratio Range Over the Past 10 Years
Min: 4.55  Med: 20.75 Max: 49.28
Current: 29.16
4.55
49.28
Forward PE Ratio 18.87
ADUS's Forward PE Ratio is ranked lower than
52% of the 83 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. ADUS: 18.87 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 29.45
ADUS's PE Ratio without NRI is ranked lower than
62% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 27.32 vs. ADUS: 29.45 )
Ranked among companies with meaningful PE Ratio without NRI only.
ADUS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 2.97  Med: 21.18 Max: 51.52
Current: 29.45
2.97
51.52
PB Ratio 2.20
ADUS's PB Ratio is ranked lower than
53% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 2.28 vs. ADUS: 2.20 )
Ranked among companies with meaningful PB Ratio only.
ADUS' s PB Ratio Range Over the Past 10 Years
Min: 0.38  Med: 1.46 Max: 3.02
Current: 2.2
0.38
3.02
PS Ratio 0.87
ADUS's PS Ratio is ranked higher than
66% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. ADUS: 0.87 )
Ranked among companies with meaningful PS Ratio only.
ADUS' s PS Ratio Range Over the Past 10 Years
Min: 0.07  Med: 0.6 Max: 1.32
Current: 0.87
0.07
1.32
EV-to-EBIT 20.28
ADUS's EV-to-EBIT is ranked lower than
54% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. ADUS: 20.28 )
Ranked among companies with meaningful EV-to-EBIT only.
ADUS' s EV-to-EBIT Range Over the Past 10 Years
Min: -11.5  Med: 11.55 Max: 34.7
Current: 20.28
-11.5
34.7
EV-to-EBITDA 14.38
ADUS's EV-to-EBITDA is ranked lower than
56% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 14.29 vs. ADUS: 14.38 )
Ranked among companies with meaningful EV-to-EBITDA only.
ADUS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -23.9  Med: 9.65 Max: 21
Current: 14.38
-23.9
21
PEG Ratio 6.53
ADUS's PEG Ratio is ranked lower than
79% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 3.12 vs. ADUS: 6.53 )
Ranked among companies with meaningful PEG Ratio only.
ADUS' s PEG Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 7.24
Current: 6.53
0
7.24
Current Ratio 2.64
ADUS's Current Ratio is ranked higher than
87% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. ADUS: 2.64 )
Ranked among companies with meaningful Current Ratio only.
ADUS' s Current Ratio Range Over the Past 10 Years
Min: 1.66  Med: 2.2 Max: 2.64
Current: 2.64
1.66
2.64
Quick Ratio 2.64
ADUS's Quick Ratio is ranked higher than
89% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.16 vs. ADUS: 2.64 )
Ranked among companies with meaningful Quick Ratio only.
ADUS' s Quick Ratio Range Over the Past 10 Years
Min: 1.66  Med: 2.2 Max: 2.64
Current: 2.64
1.66
2.64
Days Sales Outstanding 106.58
ADUS's Days Sales Outstanding is ranked lower than
91% of the 174 Companies
in the Global Medical Care industry.

( Industry Median: 44.22 vs. ADUS: 106.58 )
Ranked among companies with meaningful Days Sales Outstanding only.
ADUS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.05  Med: 95.65 Max: 114.79
Current: 106.58
76.05
114.79
Days Payable 5.56
ADUS's Days Payable is ranked lower than
96% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. ADUS: 5.56 )
Ranked among companies with meaningful Days Payable only.
ADUS' s Days Payable Range Over the Past 10 Years
Min: 5.56  Med: 7.3 Max: 11.4
Current: 5.56
5.56
11.4

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.70
ADUS's 3-Year Average Share Buyback Ratio is ranked higher than
52% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. ADUS: -1.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ADUS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -119.5  Med: -1 Max: -0.5
Current: -1.7
-119.5
-0.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 5.91
ADUS's Price-to-Net-Current-Asset-Value is ranked higher than
56% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. ADUS: 5.91 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ADUS' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.85  Med: 5.97 Max: 26.29
Current: 5.91
1.85
26.29
Price-to-Tangible-Book 5.05
ADUS's Price-to-Tangible-Book is ranked lower than
67% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: 3.25 vs. ADUS: 5.05 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ADUS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.39  Med: 4.59 Max: 12.07
Current: 5.05
1.39
12.07
Price-to-Intrinsic-Value-Projected-FCF 1.45
ADUS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
58% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. ADUS: 1.45 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ADUS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.11  Med: 1.38 Max: 1.67
Current: 1.45
1.11
1.67
Price-to-Median-PS-Value 1.43
ADUS's Price-to-Median-PS-Value is ranked lower than
80% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. ADUS: 1.43 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ADUS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.15  Med: 0.92 Max: 1.65
Current: 1.43
0.15
1.65
Price-to-Graham-Number 2.55
ADUS's Price-to-Graham-Number is ranked lower than
59% of the 117 Companies
in the Global Medical Care industry.

( Industry Median: 2.23 vs. ADUS: 2.55 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ADUS' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.53  Med: 2.05 Max: 2.93
Current: 2.55
0.53
2.93
Earnings Yield (Greenblatt) % 4.96
ADUS's Earnings Yield (Greenblatt) % is ranked higher than
58% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.94 vs. ADUS: 4.96 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ADUS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.9  Med: 8.5 Max: 44.4
Current: 4.96
2.9
44.4
Forward Rate of Return (Yacktman) % 1.62
ADUS's Forward Rate of Return (Yacktman) % is ranked lower than
72% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 10.02 vs. ADUS: 1.62 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ADUS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 1  Med: 1.7 Max: 4
Current: 1.62
1
4

More Statistics

Revenue (TTM) (Mil) $400.7
EPS (TTM) $ 1.05
Beta-0.18
Short Percentage of Float2.76%
52-Week Range $15.33 - 37.35
Shares Outstanding (Mil)11.53

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 429 450
EPS ($) 1.61 1.86
EPS without NRI ($) 1.61 1.86
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.00%
Dividends per Share ($)
» More Articles for ADUS

Headlines

Articles On GuruFocus.com
100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 

More From Other Websites
Allergan's Restasis Now Available in Multidose Bottle in U.S. Mar 23 2017
Ultragenyx's Seizure Candidate UX007 Fails in Phase II Study Mar 23 2017
ADDUS HOMECARE CORP Financials Mar 18 2017
Owens & Minor (OMI) Reaffirms Tepid 2017 Financial Guidance Mar 17 2017
Jazz Initiates Phase III Study for Narcolepsy Candidate Mar 16 2017
Conatus Pharma (CNAT) Incurs Wider-than-Expected Loss in Q4 Mar 16 2017
TrovaGene (TROV) Reports Wider-than-Expected Loss in Q4 Mar 16 2017
ADDUS HOMECARE CORP Files SEC form 10-K, Annual Report Mar 15 2017
Addus HomeCare To Participate In Oppenheimer 27th Annual Healthcare Conference Mar 14 2017
Cogentix (CGNT) Q4 Earnings and Revenues Miss Estimates Mar 10 2017
Addus HomeCare Corp. :ADUS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017 Mar 09 2017
ADDUS HOMECARE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Change in... Mar 06 2017
Addus HomeCare posts 4Q profit Mar 06 2017
Addus HomeCare posts 4Q profit Mar 06 2017
Addus HomeCare Announces Fourth-Quarter 2016 Results Mar 06 2017
Q4 2016 Addus Homecare Corp Earnings Release - After Market Close Mar 06 2017
Addus Homecare Announces Fourth Quarter and Year-End 2016 Earnings Release and Conference Call Feb 13 2017
Addus HomeCare Corp. – Value Analysis (NASDAQ:ADUS) : January 23, 2017 Jan 23 2017
Addus HomeCare Corp. breached its 50 day moving average in a Bearish Manner : ADUS-US : January 20,... Jan 20 2017
ADDUS HOMECARE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Jan 18 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)